Neuroscience • Medicine • Exponentials • Biotech
Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator and is serving as the Chair of the XPRIZE Pandemic Alliance Task Force. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has chaired the Medicine for Singularity University since its inception in 2008, and is founder and chair of Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare. Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children’s Hospital, and fellowships in hematology, oncology and bone marrow transplantation at Stanford.
Daniel chair the XPRIZE Pandemic Alliance Task Force. He is often called upon to speak to the future of health, medicine and technology and has given 5 TED and TEDMED Talks.
He has multiple scientific publications and medical device, immunology and stem cell-related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at the University of California San Francisco.
Daniel is a member of the Kaufman Fellows Society (Class 13) and member of the Inaugural (2015) class of the Aspen Institute Health Innovators Fellowship.
Daniel’s academic research has focused on: stem cell biology and regenerative medicine, stem cell derived immunotherapies for cancer, bioengineering human T-cell differentiation, and humanized animal models. His research has been published in journals that include Nature and Science. His clinical work has focused on: bone marrow / hematopoietic stem cell transplantation for malignant and non-malignant diseases in adults and children, medical devices to enable stem cell-based regenerative medicine, including marrow-derived stem cell harvesting, processing, and delivery. He also implemented the first text-paging system at Stanford Hospital.
He is heavily involved in digital health, founded Digital.Health, and is on the board of Healthy.io and advises several digital health-related startups and established healthcare organizations. Daniel recently founded IntelliMedicine, focused on personalized, data-driven, precision medicine. He is also the inventor of the MarrowMiner, an FDA approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell based regenerative therapies.
Daniel is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeon with F-15 & F-16 fighter Squadrons. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.
The Future of Medicine and Healthcare Comprehensive overview of what is in the lab today and what is coming to market in the next 2 to 10 years. The presentation will concentrate on breakthrough developments ranging from 3D printing to organ regeneration, from point-of-care lab-on-a-chip diagnostics to large-scale bioinformatics; from synthetic biology to new gene based therapies. All of these and more are discussed in the context of current explosions of digital information and distributed healthcare.
Design touches everything. From 3D printed artificial limbs to User Experience, design is an important aspect the defines customer experience
Patient Driven Healthcare: we’re in an era of access to information, which is empowering patients to be a key decision maker on the healthcare team
From Robotic Surgery, Bionic limbs and exoskeletons, Smart pills, and Implantable Devices, to targeted gene therapy, and ever shrinking and more capable devices, Nanomedicine.
How convergent technology will impact the practice of medicine, new models of care from concierge to telemedicine.
The data explosion… from Electronic Medical Records, Quantified Self, Imaging & Diagnostics to Mobile & Internet Enabled Health
Innovating mindset, design thinking, funding, opportunities and barriers (regulatory and otherwise) of biomedical innovation.
Real time brain imaging, Brain computer interface (BCI), Cognitive Enhancement, Targeted neurointervention, Psychiatry and Behavioral Medicine.
Systems medicine & biology to the rapidly emerging world of Synthetic Biology, Diagnostics and DIY Biology
Stem cells & beyond, cellular alchemy to 3-D printing of organs and tissues.
Comprehensive overview of what is in the lab today and what is coming to market in the next 2 to 10 years. The presentation will concentrate on breakthrough developments ranging from 3D printing to organ regeneration, from point-of-care lab-on-a-chip diagnostics to large-scale bioinformatics; from synthetic biology to new gene based therapies. All of these and more are discussed in the context of current explosions of digital information and distributed healthcare.